Source facts
FDA posted an approval letter for CALQUENCE on 2026-02-23. This is the document posting date; consult the signed letter for the decision date. The source metadata identifies NDA 210259, NDA 216387 as a supplement. Review the exact FDA letter for the approved conditions and labeling.
